An inhibitor of BD1 in BRD4
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

OXF BD 02

Item No. 14811

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-(3,5-dimethyl-4-isoxazolyl)-5-hydroxy-α-phenyl-benzenemethanol
CAS Number
1429129-68-9
Synonyms
  • BRD4 Inhibitor Compound 8
Molecular Formula
C18H17NO3
Formula Weight
295.3
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Slightly soluble: 0.1-1 mg/ml
SMILES
OC(C1=CC(O)=CC(C2=C(C)ON=C2C)=C1)C3=CC=CC=C3
InChi Code
InChI=1S/C18H17NO3/c1-11-17(12(2)22-19-11)14-8-15(10-16(20)9-14)18(21)13-6-4-3-5-7-13/h3-10,18,20-21H,1-2H3
InChi Key
FEQUIPXIENTMJN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $248

    Add

    10 mg

    $396

    Add

    25 mg

    $743

    Add

    50 mg

    $990

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    OXF BD 02 is an inhibitor of bromodomain 1 (BD1) in bromodomain-containing protein 4 (BRD4; IC50 = 382 nM).1 It is selective for BRD4 BD1 over a panel of 60 bromodomain-containing proteins but does inhibit CREB-binding protein (CBP) at 25 µM. OXF BD 02 is cytotoxic to MV4-11 acute myeloid leukemia (AML) cells (IC50 = 0.794 nM) but not A549 or H1975 lung cancer cells (IC50s = >10 µM for both) or U2OS osteosarcoma or HeLa cervical cancer cells (IC50s = >100 µM for both). OXF BD 02 also binds to recombinant S. mansoni BRD3 (SmBRD3) that contains BD1 and BD2 (Kd = 683 nM) but not recombinant BD2 of SmBRD3.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hewings, D.S., Fedorov, O., Filippakopoulos, P., et al. Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. J. Med. Chem. 56(8), 3217-3227 (2013).

    2. Schiedel, M., McArdle, D.J.B., Padalino, G., et al. Small molecule ligands of the BET-like bromodomain, SmBRD3, affect Schistosoma mansoni survival, oviposition, and development. J. Med. Chem. 66(23), 15801-15822 (2023).